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SUMMARY 
 
The use of prophylactic antibiotics in oral surgery is widespread and often 
inappropriate. Appropriate antimicrobial treatment greatly improves the 
prognosis of infectious disease. However, the indiscriminate use of antibiotics 
may increase the risks of drug resistant pathogens, side effects and cost of 
medical care 
 
 In the latest review article (Antibiotic prophylaxis for dentoalveolar surgery: is it 
indicated), Lawler (2005) summarizes that there are no randomized controlled 
clinical studies of antibiotic prophylaxis for dentoalveolar surgery, including third 
molar removal and dental implantation. Other less rigorous studies show 
conflicting and commonly equivocal results. 
 
The use of prophylactic antibiotics to reduce postoperative complications in third 
molar surgery remains controversial. Some authors favour routine prophylaxis. 
Some suggest it to be indicated with the difficult cases only, while others report 
no benefit. However, any antibiotic when used prophylactically, will only provide 
adequate protection when effective levels are present at the time of bacterial 
contamination. The recommended standard antibiotic regimen for odontogenic 
infections is still penicillin.  The antibiotics amoxicillin, ampicillin and Pen-V are 
equally effective in vitro against Alfa-haemolytic streptococci; however, 
amoxicillin is recommended, because it is better absorbed from the GI tract and 
provides higher and more sustained serum levels. 
 
The purpose of this study is to evaluate the need for prophylactic antibiotic 
treatment in third molar surgery and to establish specific guidelines for antibiotic 
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prophylaxis in the department of Maxillo-Facial and Oral Surgery (MFOS) at 
Tygerberg Academic, Groote Schuur and Mitchells Plain Hospitals. 
 
The study was designed as a prospective, randomized, double blind, placebo 
controlled clinical trial in which the patients were randomly assigned to two 
groups. The two groups were paired using radiographs and Pell and Gregory 
classification. The surgery was performed under local anaesthesia. The first 
group received a stat dose of antibiotics (Amoxicillin 1 gm, 1- hour before the 
start of operation). The second group  received a 1 gm stat dose of antibiotics 
and then 500 mg 8 hourly orally for two days, which is the current empiric 
protocol used by the MFOS unit at Tygerberg. Each group functioned as its own 
control. Two wisdom teeth were removed under antibiotic cover and two 
removed without antibiotic cover. Neither patient nor surgeon knew which teeth 
were removed under antibiotic cover. 
 
Pain, swelling, infection/ purulent discharge, inter-incisal mouth opening / 
trismus and temperature were recorded on the third, seventh and fourteenth day 
of surgery. We compared the complication rates of these two groups. Any side-
effects (possible) related to antibiotics were also recorded. 
 
The results of the study showed that the prophylactic antibiotics do not provide 
additional effects on postoperative infections. There is therefore no justification 
to use antibiotics routinely for third molar surgery. However, we need a safe and 
effective analgesic and anti-inflammatory combination after third molar surgery 
to prevent post-operative pain. 
 
From the results of our study, we believe that single dose pre-operative 
prophylaxis is a scientifically based way to minimize the infection rate and costs 
in a hospital setting. 
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CHAPTER -1 
 
INTRODUCTION 
 
 
Antibiotic prophylaxis is defined as the use of antibiotics to prevent infection.     
Infection occurs when there is a significant quantitative and qualitative bacterial 
insult. 
 
Prevention of infection can be accomplished by achieving two goals. 
1. Reducing the number of bacteria in the surgical wound. 
2. Enhancing host defense so as to prevent the bacteria that inevitably enter 
the wound from causing clinically evident infection. 
Burke (1961) established that the maximum effectiveness of prophylactic 
antibiotics occurs when the antibiotic is in the tissue when bacteria arrive (Burke 
et al, 1961). 
 
Appropriate antimicrobial treatment greatly improves the prognosis of infectious 
disease. However, the indiscriminate use of antibiotics may increase the risks of 
drug resistant pathogens, side effects and cost of medical care. World wide many 
strains of staphylococcus aureus exhibit resistance to antimicrobial drugs, 
including vancomycin. Methicillin resistant staphylococcus aureus is one of the 
most frequent nosocomial pathogens (Zeitler et al, 1995). In central Africa, some 
strains of shigella are no longer sensitive to quinolone antibiotics. Therefore it 
has become problem to treat recent outbreaks and thousands have died. 
 
Penicillin resistant Staphylococcus pneumoniae has passed resistant genes to the 
previously susceptible staphylococcus viridans species (ADA Council on scientific 
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affairs 2004).  Antibiotic prophylaxis for surgical infections requires specific 
dosing schedules (perioperative surgical prophylaxis) to be successful. 
 
Peterson in 1990 established principles of antibiotic prophylaxis 
 
  Principle I       The surgical procedure should have a significant risk of infection 
  Principle II      Select the correct antibiotic for the surgical procedure. 
  Principle III     The antibiotic level must be high. 
  Principle IV     Time the antibiotic administration correctly.  
  Principle V       Use the shortest effective antibiotic exposure. 
 
Peterson (1990) also classified surgical procedures by expected degree of 
contamination, and the expected incidence of post-operative infections. 
 
Peterson Classification (JOMS 1990:48) 
 
Class I surgery, also known as clean surgery, occurs when no transaction of the 
respiratory, gastrointestinal, or urinary tracts occurs, and there is no break in 
surgical-aspect technique. It has an infection rate of approximately 2%, and it 
can be reduced to less than 1% by good surgical technique. 
 
Class II surgery, clean contaminated surgery, exists when no significant bacterial 
contamination results. Trans-oral surgery is considered to be in this class. The 
expected infection rate in clean contaminated surgery is 10% to 15%, and it can 
be reduced to approximately 1% by a good surgical technique and prophylactic 
antibiotics. 
 
In class III surgery (contaminated surgery) the infection rate is 20% to 30%, 
and by excellent technique and prophylactic antibiotics it can be reduced to 10%.  
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Class IV surgery (dirty) surgery exists when there is established clinical infection 
or a traumatic injury of more than 8 hours old. It has an infection rate of nearly 
50% (Peterson 1990; Pallasch et al, 1989). 
 
Third molar surgery (trans-oral) falls into the category of clean contaminated 
surgery. If the use of antibiotics for third molar surgery is to be recommended, 
Peterson’s principle I must be proved. 
 
However, there are sufficient reports on complications associated with antibiotic 
usage to raise the question of whether the possible risks of prophylaxis do not 
outweigh any minor benefits? When approximately 5% of patients receiving 
antibiotics have adverse reactions (Laskin, 2003; Stone et al, 1979), many of 
which are severe or life threatening, it seems appropriate to evaluate the 
potential value of prophylactic antibiotic in third molar surgery.  
 
There are no randomized controlled clinical studies of antibiotic prophylaxis for 
dento-alveolar surgery, including third molar removal and dental implantation. 
Other less rigorous studies show conflicting and commonly equivocal results 
(Stuart et al, 2004). 
 
The recommended standard antibiotic regimen for odontogenic infections is still 
penicillin.  The antibiotics amoxicillin, ampicillin and Pen-V are equally effective in 
vitro against Alfa-hemolytic streptococci; however, amoxicillin is recommended 
because it is better absorbed from the GI tract, provides higher and more 
sustained serum levels (Lawler et al, 2005). 
 
The aim of this study was to establish specific guidelines for prophylaxis in third 
molar surgery in the department of MFOS at Tygerberg Academic, Groote Schuur 
and Mitchells Plain hospitals. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1. INTRODUCTION 
2.1.1. Spread of dental Infection  
The healthy body usually lives in balance with a number of resident normal flora. 
However, pathogens can invade and initiate an infectious process. Dental 
infections involving the teeth or associated tissues are caused by oral pathogens 
that are predominantly anaerobic and usually of more than one species. These 
infections can be of dental origin or from a non-odontogenic source. Those of 
dental origin usually originate from progressive dental caries or extensive 
periodontal disease. Pathogens can also be introduced deeper into the oral 
tissues by the trauma. Treatment entails removal of the source of infection, 
systemic antibiotics and drainage. 
2.1.2. Antibiotic prophylaxis 
Antibiotic prophylaxis is defined as the use of antibiotics to prevent infection. 
Infection occurs when there is a significant quantitative and qualitative bacterial 
insult (Peterson et al, 1990). Appropriate antimicrobial treatment greatly 
improves the prognosis of infectious disease. However, the indiscriminate use of 
antibiotics may increase the risks of drug resistant pathogens, side effects and 
increased costs of medical care.  
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2.1.3. Principles of antibiotic prophylaxis 
 
Indications: Criteria for use: 
1) The health benefits must outweigh the antibiotic risks 
2) The cost-benefit ratio must be acceptable 
3) The antibiotic must be in the blood/target tissue before surgery 
4) An antibiotic loading dose should be used  
5) The choice of the antibiotic should be made on the single most likely 
microorganism to cause an infection 
6) The antibiotic should be continued only as long as the microbial 
contamination of or from the operative site continues (Burke et al, 1961; 
Stone et al, 1979) 
  
Contraindications:  
1) Prophylaxis is random in efficacy to be reliable 
2) The bacteremia to be prevented is seldom a cause of disease 
3) Prophylaxis is directed at any/all potential pathogens rather than the 
colonization of a single microbial pathogen (Burke et al, 1977; Polk et al, 
1969) 
 
Indications for surgical prophylaxis: 
1) In clean-clean surgery where the risk of infection is remote, but its 
potential consequences are grave or in clean-contaminated surgery, 
where the likelihood of infections is great but seldom fatal 
2) To prevent contamination of a sterile area 
3) Where infection is unlikely but is associated with major morbidity 
4) In surgical procedures with high infection rates 
5) During implantation of prosthetic material to prevent bacterial endocarditis 
(Stone et al, 1984; Paluzzi et al, 1993)     
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Adverse effects: 
1) Increased risk of antibiotic toxicity or allergy 
2) Increased risk of super-infections 
3) Selection of antibiotic-resistant microorganisms 
4) Induction of resistance gene expression or transfer (New HC, 1979) 
 
Based on these principles, the use of antibiotics to ‘‘prevent’’ postoperative 
complications after treatment is inappropriate, as the drug is not in the system 
before microbial contamination. This is another violation of the basic principles of 
prophylaxis. Often the drug is then continued for many days after the procedure, 
which allows for selection of resistant bacteria or resistance gene expression or 
transfer. 
 
Orofacial infections after dental procedures are uncommon. The only possible 
indication for surgical antibiotic prophylaxis in the oral cavity is implant 
placement. No clinical studies have adequately documented the efficacy of peri-
operative antibiotic prophylaxis in the prevention of orofacial infections. 
 
2.2. INFECTIVE ENDOCARDITIS (IE) 
 
Infective endocarditis (IE) is a microbial infection of the endocardial surfaces 
usually involving the cardiac valves. The condition is relatively uncommon with a 
prevalence of 11–50 cases per million population per year (Young, 1987).  
 
Dental procedures, especially those that result in a bacteraemia, are frequently 
blamed for IE, hence the need for antibiotic prophylaxis to cover such 
procedures in patients at risk. This has been the clinical doctrine and teaching for 
the past 50 years. Recent evidence from the USA (Strom et al, 1998) and studies 
from the Netherlands (Van der Meer et al, 1992; 1996) have presented further 
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data which challenges the practice of prescribing antibiotics before dental 
procedures to prevent endocarditis. This information also needs to be considered 
in tandem with the increasing concern over the indiscriminate use of antibiotics.  
 
2.2.1. British Society of Antimicrobial Chemotherapy (BSAC)   
guidelines for antibiotic prophylaxis (www.bes.com/library) 
   
Conditions predisposing to risk of infective endocarditis 
• History of infective endocarditis 
• Ventricular septal defect 
• Patent ductus arteriosus 
• Coarctation of the aorta 
• Prosthetic heart valves 
• Rheumatic and other acquired valvular disease 
• Surgical constructed systemic-pulmonary shunts 
• Persistent heart murmur 
• Atrial septal defect repaired with a patch 
• Hypertrophic cardiomyopathy 
• Marfan’s syndrome 
 
Patients not at risk from infective endocarditis 
• After coronary by-pass surgery 
• Six months after surgery for: 
• Ligated ductus arteriosus 
• Surgically closed atrial or ventricular septal defects (without Dacron ® 
patch) 
• Isolated secundum atrial septal defect 
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Special risk patients 
• Those with a previous history of infective endocarditis 
• Those that require a general anaesthetic and have a prosthetic heart 
valve, are allergic to penicillin or who had had penicillin more than once in 
the previous month (Seymour et al, 2000) 
 
2.2.2. ANTIBIOTIC REGIMENS (BSAC) 
 
Local or no anaesthesia 
 
No allergy to penicillin 
Amoxycillin 3g orally 1 before operation 
 
Allergic to penicillin 
Clindamycin 600mg orally 1 hour before operation 
 
General anaesthesia  
 
No allergy to penicillin 
Amoxycillin (3g) and probenecid (1g) orally 4 hours before procedure or 
amoxycillin (3g) orally 4 hours before and 3 g after surgery or amoxycillin (1g) 
intravenously at induction and 500mg orally 6 hours later 
 
Allergic to penicillin 
These patients are classified as special risk patients  
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Special risk patients 
 
No allergy to penicillin 
Intravenous amoxycillin 1g and intravenous gentamicin (120mg) before surgery 
or at induction, and amoxicillin (500mg) orally 6 hours later 
 
Allergic to penicillin 
Intravenous teicoplanin (400mg) and intravenous gentamicin (120mg) before 
procedure or at induction or clindamycin (300mg) given intravenously over 10 
minutes in 50 ml before surgery or at induction and 150mg (oral or intravenous) 
6 hours later or vancomycin (1g slow intravenous infusion over not less than 100 
minutes), followed by gentamicin (120mg intravenous) before surgery or at 
induction. 
 
Dosage for children: 
Amoxycillin or clindamycin:  Children under 10 years, half the adult dose 
                                        Children under5 years, one-quarter of adult dose                 
Vancomycin:                      Children under 10 years, 20 mg/kg            
Gentamicin:                       Children under 14 years, 6mg/kg (or 2mg/kg if with 
  teicoplanin 
  
                                    Children under 10 years, 2 mg/kg           
Teicoplanin:                        Children under 14, 6 mg/kg 
 
Amoxycillin may be given twice in one month as it is unlikely that proliferation of 
clinically significant amoxycillin-resistant strains will occur after one 3 g dose of 
amoxycillin. A third dose of amoxycillin, however, should not be given until after 
an interval of one month. Two weeks should elapse between prophylactic doses 
of clindamycin (Ramsdale et al, 2005; Seymour et al, 2000 and 2002; Lesley et 
al, 1993). 
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2.2.3. AMERICAN HEART ASSOCIATION GUIDELINE FOR              
ANTIBIOTIC PROPHYLAXIS (JAMA, JUNE 11, 1997- VOL 227, NO. 22) 
 
Cardiac conditions associated with endocarditis 
High risk category 
• Prosthetic heart valves, including bioprosthetic and homograft valves 
• Previous bacterial endocarditis 
• Complex cyanotic congenital heart disease (e.g. single ventricle states, 
transposition of   the great arteries, tetralogy of Fallot. 
• Surgically constructed systemic pulmonary shunts or conduits  
 
Moderate risk category 
• Most other congenital cardiac malformations 
• Acquired valvular dysfunction (e.g. rheumatic heart disease) 
• Hypertrophic cardiomyopathy 
• Mitral valve prolapse with valvular regurgitation and/or thickened leaflets 
 
Negligible-risk category (no greater risk than the general population) 
• Isolated secundum atrial septal defect 
• Surgical repair of atrial septal defect, ventricular septal defect, or patent 
ductus arteriosis (without residue beyond 6 months) 
• Previous coronary artery by-pass graft surgery 
• Mitral valve prolapse without valvular regurgitation 
• Physiologic, functional or innocent heart murmurs 
• Previous Kawasaki disease without valvular dysfunction 
• Previous rheumatic fever without valvular dysfunction 
• Cardiac pacemakers and implanted defibrillators 
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2.2.4. ANTIBIOTIC REGIMENS (AHA) 
 
 Standard general prophylaxis 
Adults:          Amoxycillin 2g 
Children:       Amoxycillin 50mg/kg 1 hour before procedure 
 
Unable to take oral medications 
Adults:          Ampicillin 2g iv or im 
Children:       Ampicillin 50mg/kg im or iv within 30 minutes before procedure 
 
Allergic to penicillin  
Adults:          Clindamycin 600mg 
Children:       Clindamycin 20mg/kg 1 hour before procedure 
Or 
Adults:          Azithromycin or Clarithromycin 500mg 
Children:     
Azithromycin or Clarithromycin 15mg/kg orally 1 hour before   
surgical procedures for which antibiotic prophylaxis is 
recommended 
  
Allergic to penicillin before procedure and unable to take oral 
medication 
 
Adults:              Clindamycin 600 mg iv or im 
Children:           Clindamycin 20 mg/kg iv within 30 minute 
                        (Ramsdale et al, 2005; Seymour et al, 2000 and 2002) 
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Dental Procedures for Which Antibiotic Prophylaxis Is Recommended 
To Prevent Infective Endocarditis (AHA Recommendations) 
• Dental extractions 
• Periodontal procedures, including surgery, scaling, root planning, probing 
periodontal   pockets and recall maintenance 
• Dental implant placement and re-implantation of avulsed teeth 
• Endodontic (root canal) instrumentation or surgery beyond the apex 
• Subgingival placement of antibiotic fibers or strips 
• Initial placement of orthodontic bands, but not brackets 
• Intra-ligamentary local anaesthetic injections 
• Prophylactic cleaning of teeth or implants where bleeding is anticipated 
• Incision and drainage or other procedures involving infected tissues 
2.3. THIRD MOLAR SURGERY 
2.3.1. Impacted teeth 
 
Impacted teeth can be defined as those teeth that are prevented from eruption 
due to a physical barrier within the path of eruption (Farman, 2004). The term 
impaction was defined by Peterson as one that fails to erupt into the dental arch 
within the expected time (Peterson, 1998). Another definition states that an 
impacted tooth is one which, for various reasons does not erupt into the correct 
position in the dental arch at the appropriate time (Archer, 1966).  
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2.3.2. Etiology of impaction 
 
The main cause of impactions is a lack of space. The third molars are the last 
teeth to erupt and for this reason they are the teeth mostly affected (Richardson, 
1975).  
Bjork et al (1956) examined the different factors which influence the lack of 
space in third molar eruption, and found that three factors are involved with 
space shortage, they are as follows 
 
1. Reduced rate of growth in the length of the mandible, in which there is 
insufficient increase in the length of the mandible in proportion to the 
amount of tooth substance. 
2. Vertical direction of the condylar growth, which is associated with 
insufficient resorption at the anterior ramus border. 
3. Back-ward directed eruption of the dentition, which cause a decrease in 
space for third molars to erupt. 
4. Retarded maturation of dentition is a fourth factor contributing to 
incomplete eruption (Björk et al; 1956). 
 
Richardson (1980) indicated that if third molar formation is delayed beyond the 
age of 10 years, the possibility of all four third molars developing is reduced by 
about 50%. She found no significant differences in the size of early and late 
developing third molars. 
 
Impaction of mandibular third molars can develop due to a decrease in the 
angulation of the mandible; an increase in the angulation of the mandibular 
plane; or third molars may remain in the same developmental angular position 
(Richardson, 1980). Lack of attrition and occlusal forces on the dentition 
associated with processed foods lead to a decreased forward movement of the 
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dentition, which may then prevent eruption of third molars. This theory was 
claimed by (Begg, 1954).  
 
Richardson (1977), in his study found that patients with a skeletal class II 
occlusion were more prone to present with impacted mandibular third molars, 
that the mandible was smaller in patients with impacted teeth, that an acute 
gonial angle among patients with impacted third molars were present, and he 
also noted that the size of impacted third molars were larger than the erupted 
third molars. 
 
The relation between the root angulation and impaction has also been studied 
and it was shown that angulated roots were more common in impacted 
mandibular third molars as compared to erupted mandibular third molars 
(Yamaoka et al, 1997). 
 
Impacted mandibular third molars may be influenced genetically. Some studies 
showed that impacted canines and mandibular molars occur more commonly in 
familial settings (Peck et al, 2002). 
 
2.3.3. Classification of impacted teeth 
Most classifications of third molar impactions are based on the analysis of 
periapical or more commonly, panoramic radiographs.  Maxillary and mandibular 
third molars are traditionally classified radiographically by angulation, their 
vertical relationship with the crown of the adjacent second molar, and, for 
mandibular third molars, their spatial relationship with the ascending ramus of 
the lower jaw (Pell and Gregory, 1933).  
 
Predicting the degree of surgical difficulty based on traditional 
classifications is useful but not universally applicable. The ultimate predictors of 
 
 
 
 
 - 15 -
surgical difficulty are procedure length, postoperative recovery developments, 
and surgical complications. Patient factors that contribute to challenging third 
molar surgery can be grouped into categories of anatomy, physiology, and 
response to anesthesia. Obesity is an increasing health problem that affects the 
practice of oral and maxillofacial surgery (Winter, 1926). Advanced aged patients 
are more likely to be medically compromised, have atrophic mandibles, and be at 
greater risk for jaw fracture or poor recovery from nerve injury. 
 
Contemporary classifications of third molars and the associated ‘‘difficulty index’’ 
described by Pedersen (1988) are not universally accepted as predictors of third 
molar surgical difficulty (Diniz-Freitas et al, 2006). The spatial relationship of a 
third molar is not as important as surgical access, balanced anesthesia, bone 
density, and the absence of dilacerated roots. The relationship of dilacerated root 
apices of a mandibular third molar to the inferior alveolar canal is a certain 
measure of difficulty and increased risk. A superiorly positioned developing upper 
third molar in close proximity to the maxillary sinus in a young patient with 
limited space between the maxillary tuberosity and the anterior border of the 
mandibular ramus predicts difficult surgery. Poorly anesthetized patients, who 
are moving and verbalizing can make the simplest of third molar surgeries 
difficult. 
 
The Pell and Gregory classification relates the position of the impacted 
mandibular third molar to the ramus of the mandible in an anterior-posterior 
direction (Pell and Gregory, 1942), as shown in Fig-1. 
 
When the mesiodistal diameter of the third molar crown is completely anterior to 
the anterior border of the ramus, it is considered a ramus class I relationship. 
Such a tooth can be angled in a mesial, distal, or vertical direction. The likelihood 
for normal eruption is best for a class I tooth with a vertical angulation. 
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 In a Pell and Gregory ramus class II relationship, approximately one half 
the mesiodistal diameter of the mandibular third molar is covered by the ramus 
of the mandible. The distal aspect of the crown of teeth in this position is 
covered by bone and soft tissue. Teeth so positioned are particularly susceptible 
to caries and pericoronitis. 
 
 A Pell and Gregory ramus class III relationship involves an impacted 
mandibular third molar that is located completely within the ramus. The 
accessibility of a class III impaction is such that it should be considered the most 
difficult tooth to remove. A mandibular third molar in a class I relationship should 
not be difficult to remove, whereas a class II relationship would be more difficult 
than a class 1 relationship but less difficult than a class III relationship. 
 
 
Fig-2.1 Mandibular third molars classified by their spatial relationship 
to the anterior border of the ascending mandibular ramus 
 
This relationship is important because the less space there is available between 
the second molar and the ascending ramus the more likely it is that the third 
molar will be impacted.  
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• Class I impaction, in which mandibular third molar has sufficient room 
anterior to the anterior border of the ramus to erupt. 
• Class II in which half of the impacted third molar is covered by the ramus. 
• Class III, in which the impacted third molar is completely embedded in the 
ramus of the mandible. 
 
Fig- 2.2 Classification of impacted third molars according to the depth 
 
Pell and Gregory classification based on relationship to the occlusal plane.  
Level A denotes that the crown of the impacted tooth is at or above the occlusal 
plane of the second molar.  
Level B denotes that the crown of the third molar is between the occlusal line 
and the cervical line of the second molar. 
Level C indicates that the crown of the third molar is beneath the cervical line of 
the second molar. 
 (Ashoo and Powers, 2000)  
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Fig- 2.3 Classification system for impacted third molars according to 
angulations 
 (A) Mesioangular lower and upper third molar impactions. 
 (B) Horizontal lower and upper third molar impactions. 
 (C) Vertical lower and upper third molar impactions. 
 (D) Distoangular lower and upper third molar impactions. 
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Classification for the maxillary third molars  
 
Pell and Gregory classified maxillary third molars based on the relationship to the 
occlusal plane. 
Class A, in which the occlusal plane of third molar is level with that of the second 
molar. 
Class B, in which the occlusal plane is between the occlusal plane of the second 
molar and its cervical line. 
Class C, in which the occlusal plainof the impaction is below the cervical line of 
the second molar. 
(Farish et al, 2007) 
 
2.3.4. Indications and contraindications for the removal of 
impacted third molars 
 
The rising standard of living associated with health education has created a 
demand for preventative care, including dental surgery. Especially in the time of 
fluoridation, teeth has been preserved what otherwise would have been lost 
because of tooth decay. The preservation of the first and second permanent 
molars makes impaction of third molars far more likely to occur. 
 
In 1979, a Consensus Development Conference on removal of third molars was 
held at the National Institute of Dental Research (National Institute of Health). 
More than 200 practicing dentists and scientists representing all disciplines within 
the profession met in an effort to reach general agreement on when and under 
what circumstances third molar extractions would be advised. 
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There are well-defined criteria for mandibular third molar removal such as 
recurrent peri-coronal infection, non-restorable carious lesion, cyst, tumor, and 
destruction of adjacent bone and tooth. 
 
Current predictive growth studies are not sufficiently accurate to form a basis on 
which clinical action could be justified. Bishsra et al., (1983) in his review article 
concluded that there is no conclusive evidence to indict the third molars as being 
the major etiologic factor in the post-treatment changes in incisor alignment.  
 
Third molars are best removed in younger patients for periodontal reasons and 
an expected, if not statistically confirmed, age related decrease in recovery time. 
The reduced morbidity resulted from extraction in younger patients than those in 
advanced adulthood (Van der Linden et al, 1993). Osborn et al., (1985) did a 
prospective study of complications related to mandibular third molar surgery and 
concluded that increased numbers of complications occur after the removal of 
older patients. On this basis they advocated the early, judicious removal of third 
molars. 
 
Contra-indications for the removal of impacted third molars that should be 
considered are as follows: 
• Possible damage to adjacent structures of an asymptomatic impacted 
tooth when the position is such that the removal adversely influences any 
adjacent structures 
• Compromised health status and age of the patient 
• Adequate space for eruption of the tooth 
• Abutment tooth 
• Orthodontic reasons – i.e. when first or second molars/premolars have 
been extracted 
• Transplantation of the third molar to extraction site of another molar 
• An unwilling patient should have his/her wishes respected 
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2.3.5. REMOVAL OR RETENTION OF ASYMPTOMATIC 
IMPACTED THIRD MOLAR TEETH (ISSUE)? 
The removal of impacted mandibular third molars is one of the most common 
procedures in dental surgery (Marciani, 2007; AAOMS parameters and pathways 
version 3). There seems to be no controversy about the removal of symptomatic 
impacted mandibular third molars (Koerner, 1994; Erasmus, 2002 ; National 
Institute for Clinical Excellence, 2006), but the prophylactic removal of 
asymptomatic impacted mandibular third molars may be regarded as a 
controversial procedure (Sasano et al, 2003). 
The prophylactic removal of asymptomatic impacted wisdom teeth is defined as 
the (surgical) removal of wisdom teeth in the absence of local disease. Some 
studies support the prophylactic removal of impacted mandibular third molars 
Koerner 1994, Mercier and Precious, 1992; Lytle 1993, Fuselier et al, 2002; 
Bagheri and Khan, 2007), while other studies do not advocate the prophylactic 
removal of impacted mandibular third molars (Song et al, 2000; Lida et al, 2004; 
Zhu et al, 2005; Mattes et al, 2005). These studies were based on indications, 
contraindications or surgical complications as a guideline to decide whether 
prophylactic removal should be employed or not. 
A critical review of 149 published articles was done by Mercier and Precious in 
1992. Comparison was made between the risks of non-intervention and the 
benefit of nonintervention. The risk of intervention and the benefit of 
intervention were also considered and all of this compared with each other. They 
came to the conclusion that “The case of either the removal or retention of the 
asymptomatic third molar in many instances, appears not to be clear cut.” 
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Bruce and co-workers (1980) showed pericoronitis to be the most frequent 
reason (40%) for removal of impacted third molars in different age groups. The 
age incidence of pericoronitis occurs mainly between 20 and 29 years and very 
rarely over 35. 
Of interest are the conflicting opinions on the role impacted teeth have on 
crowding of teeth. Stephens in 1989 stated; “clearly the removal of erupting 
third molars to prevent crowding of lower incisors lacks scientific support and 
cannot be used to justify preventative extraction”. On the contrary, Lindquist 
(1982) extracted third molars unilaterally and found decreased crowding on the 
extraction side, compared with the implication of the presence of erupting third 
molars as one causative factor in lower arch crowding.  
Song and co-workers (1997) makes a sweeping statement that; “In the absence 
of good evidence to support prophylactic removal there appears to be little 
justification for the removal of pathology free third molars.” Statements such as 
these grant license to ignore third molars in the dental equation! Operator 
experience has been shown to have a direct influence on post-operative 
morbidity (Sisk et al 1986). 
Song et al in 1997 concluded that the principle of preventive medicine should be 
ignored due to operator inexperience and especially financial restraints. It should 
be noted that asymptomatic does not necessarily mean pathology free. A deep 
carious tooth can be asymptomatic but certainly not pathology free.  
Mettes et al, (2005) found no evidence to support or refute routine prophylactic 
removal of asymptomatic impacted wisdom teeth in adults. There is some 
reliable evidence that suggests that the prophylactic removal of asymptomatic 
impacted wisdom teeth in adolescents neither reduces nor prevents late incisor 
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crowding. Goss in his discussion contradicts the Cochrane Review. He states that, 
“Until there is evidence to the contrary it is recommended that non-functional 
wisdom teeth are best removed in teenagers and young adults. This is sound 
preventive dentistry.” 
2.4. DISCUSSION 
Since the introduction of penicillin into human therapeutics in the 1940s, 
antibiotics have been used and misused over the past 66 years. It was the early 
1950s when the debate of antibiotic prophylaxis started. One of the earliest 
discussions published was by Altemeire and his colleagues in 1955. He 
emphasized the necessity of determining the specific indications for prophylactic 
antibiotic therapy on the basis of existing knowledge. 
2.4.1. Timing of antibiotic prophylaxis 
Bruke (1961) discussed the effective period for preventive antibiotic action in 
experimental incisions and dermal lesions. He concluded that the antibiotics 
cause maximum suppression of infection if used before bacteria gain access to 
tissue.  
The use of prophylactic antibiotics to reduce postoperative complications in third 
molar surgery remains controversial. Some authors favor routine prophylaxis 
(Zeitler, 1995; Stone, 1976; Curran 1974; Gregor, 1976). Some suggest it to be 
more valuable with the difficult cases; while others report no benefit (Goldberg, 
1985). However, prophylactic antibiotic will only provide adequate protection 
when effective levels are present at the time of bacterial contamination (Stone, 
1979). 
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2.4.2. The pioneering efforts in antibiotic prophylaxis 
The efforts of Polk (1969), Burke (1961), Stone (1979) and Weinstein provide 
the rational for the use of antibiotic prophylaxis. Piecuch, et al in 1995 looked at 
the issue of antibiotic prophylaxis especially for third molar surgery. They offered 
that the oral surgeons prescribe prophylactic antibiotics in third molar surgery for 
full bony and partial bony impactions (Stone, 1976; Barclay, 1987). Neomycin-
bacitracin cones were placed in impacted third molar sockets by Nordenram in 
1973. He found that the postoperative complications were significantly less in 
those cases where these cones had been used. 
 His trial was randomized but not blind. This study was directed more at 
evaluating a local bandage than comparing the antibiotic groups with a control, 
making it somewhat difficult to evaluate. No recommendations for antibiotic use 
on routine basis were made by these authors. 
In a 1976 editorial entitled “Prophylactic Antibiotics: A problem or panacea, 
Laskin mentioned the inappropriate use of antibiotics. He then urged that the 
hospital oral surgery departments should establish specific guidelines for 
prophylaxis and treatment. He urged the hospitals with residency programs to 
teach the trainees the proper rationale behind the choice of antibiotics, the need 
for cultures and sensitivity tests, the complications associated with use of 
antibiotics and the necessity for conservatism in prescribing the drugs. 
A randomized, double blind, placebo-controlled clinical trial compared tinidazole 
with placebo for prevention of infection after third molar surgery (Mitchell, 
1986). This study found a significant difference between the incidences of 
infection in the tinidazole group as compared with the placebo group (Mitchell, 
1986). However, the definition of infection in his study included the diagnosis of 
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alveolar socket and therefore the data presented in the article did not allow the 
reader to determine which patients actually had true infections and which had 
simple alveolar infection.  
Capuzzi saw no statistical difference in regard to pain and swelling in their 146 
patients (Capuzzi, 1994). Half of which were on postoperative amoxicillin for 4 
days and half without antibiotics. The author did not comment on the infection 
rate.  This study violated the rule of antibiotic prophylaxis that no antibiotics 
were in the soft tissue before the surgery. 
2.4.3. LITERATURE AGAINST ANTIBIOTIC USE 
Investigators, who propagate that prophylactic antibiotics should not be used, 
include Curran et al. They divided 68 patients, who had 133 mandibular bony 
impactions, into two regimen groups: 1) penicillin intramuscularly 1 hour before 
surgery followed by oral penicillin for 4 days; 2) no antibiotics. They concluded 
that the use of prophylactic antibiotics in third molar surgery is unnecessary 
unless specific systemic factors are present.  
Curran's conclusions contradicted the results because 7.8% (5 of 64) of the 
sockets that were treated with antibiotics got infected whereas 8.7% (6 of 69) of 
the sockets without antibiotics became infected. 
Happonen et a1(1990), divided 136 patients who had mandibular third molar 
extractions into three random groups, each of which was given an intramuscular 
injection 1 hour preoperatively and 15 tablets over 5 days postoperatively. Of the 
patients receiving penicillin, 13.6% (6 of 44) became infected, whereas 10.6% (5 
of 47) who received tinidazole and 11.1% (5 of 45) who received placebo 
developed infections. These differences were not statistically significant.  
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Goldberg made the statement that "antibiotic prophylaxis is not useful in the 
prevention of postsurgical wound infection". However, analysis of the data in this 
article shows that 1.1% (1 of 90) of patients receiving antibiotics developed 
infections, whereas 9.4% (20 of 212) who did not receive antibiotics developed 
infections.  
Mitchell (1986) reported an 8.8% (4 of 45) incidence in his tinidazole group 
versus a 45.4% (20 of 44) incidence in his placebo group. A subsequent 
comparison study by the same author (Mitchell, 1986) showed similar infection 
rates in groups given either of pivampicillin or tinidazole, but there was no 
control group. Some articles support the use of antibiotics on the basis of 
decreased trismus, swelling, pain, or better wound healing, but do not 
specifically comment on infection rates (MacGregor & Addy, 1980).  
One randomized prospective article by Nordenram (1973) studied bacterial 
growth in third molar sockets of 120 patients: 40 with preoperative and 
postoperative penicillin, 40 with preoperative and postoperative scopolamine (to 
reduce salivary flow), and 40 with no medication. Growth of both aerobic and 
anaerobic bacteria within the sockets was significantly decreased in the group on 
penicillin.  
 2.4.4. LITERATURE IN FAVOUR OF ANTIBIOTIC USE 
Investigators who favor the use of antibiotics include those commenting on 
direct application within sockets as well as those favoring systemic antibiotics. 
Antibiotics placed directly into the socket, including tetracycline, metronidazole, 
lincomycin and oxy-tetracycline, have been shown to be very effective in 
reducing significantly the incidence of alveolar osteitis (dry socket), whereas one 
prospective, double blind study comparing 85 patients with neomycin/bacitracin 
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cones with 59 controls showed a 7.1% infection rate in the antibiotic group and 
a 20.3% rate in the control group Nordenram (1973).  
Only one article other than Goldberg's (1985) could be sourced dealing with the 
use of systemic antibiotics and rates of infection. In the articles that documented 
a higher incidence of infection, every patient was examined after surgery. None 
of the three articles with a lower incidence makes that statement. It is possible 
that some infections in these groups were not identified as all patients were not 
examined post-operatively.  
Piecuch (1995) in his retrospective study of 6,713 third molar teeth, 
demonstrated that antibiotics appear not to be of benefit in some instances and 
are of significant benefit in other instances. The strength of his study was that it 
was the only published study with a large number of patients where all patients 
were evaluated postoperatively. Infection rates by site, by classification of 
impaction and by comparison of different antibiotic regimens were documented. 
The weakness of his study was its retrospective and nonrandomized nature 
(Lawler, 2005; Martin, 2005). 
In another double blind, prospective, placebo-controlled trial used metronidazole 
1-gram orally one hour preoperatively (44 patients), metronidazole 400mg orally 
eight-hourly for five-days (47 patients), placebo (34 patients), concluded that 
antimicrobial prophylaxis does not seem to reduce morbidity after removal of 
lower third molars (Sekhar,2001).  
In 2004, Poeschl and Eckel evaluated the need for prophylactic postoperative 
oral antibiotic treatment in the removal of asymptomatic third molars. His study 
was prospective and randomized. He used 288 patients with 528 third molar 
 
 
 
 
 - 28 -
extractions. He found no benefit for post-operative oral prophylactic treatment 
after the removal of asymptomatic third molars.  
Although the study indicates that antibiotics were given prophylactically, the 
timing of administration after surgery violates a basic principal of prophylaxis 
that the antibiotic should be within the tissues at the beginning of surgery. In 
this study the patients were given antibiotics post-operatively. The length of time 
for which antibiotics were given (5-days) should be addressed (Lieblich, 2004; 
Pallasch, 1989 i.e. he used antibiotics for 5 days post-operatively. 
2.5- CONCLUSION 
Third molar surgery is a common surgical procedure. Antibiotic prophylaxis in 
third molar surgery is the debate of the day and remains controversial (Pogrel, 
1993; Poesch, 2004; Pallasch, 1989; Poesch, 2004). Thus, a review of the 
literature reveals no clear-cut guidelines. Most of the articles discouraging 
antibiotic use are flawed in either scientific method or conclusions. Even the 
incidence of infection as quoted in the literature, seems to be contradictory. 
Many dental and oral surgical textbooks recommend against the use of 
prophylactic antibiotics for extractions, including third molar surgery, unless 
active infection is present at the time of surgery. Others recommend routine 
antibiotic use only for "deep, difficult impactions, and, for a minimum of 5 to 7 
days". 
A number of other studies have had less stringent protocols, oftentimes 
randomizing groups but not doing blind studies. These studies had a tendency to 
find more favorable outcomes in the antibiotics groups.  
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Bystedt and Nord (1980) evaluated four different antibiotics versus placebo 
observing pain, trismus, swelling, and wound healing. They found that antibiotics 
significantly reduced pain on day 7 postoperatively. In general, they found no 
statistically significant differences in trismus and swelling. Hever, there was a 
significant difference between the placebo and doxycycline groups with respect 
to swelling (day 2 postoperative, P < 0.01; day 5 postoperative, P < 0.05). They 
concluded that systemically administered antibiotics offered only slight 
advantages in routine operations of impacted third mandibular molars, but could 
decrease the rate of infections after traumatic operations. 
Krekmanov and Hallander (1980), using a randomized trial that was not blind, 
compared penicillin with scopolamine and a control group, monitoring incidence 
of alveolitis only. The frequency of alveolitis after third molar surgery was 
studied in three groups of 40 patients each. One group was pre-medicated with 
penicillin V, another with scopolamine, and the third group received no pre-
medication. The respective frequencies of alveolitis were 5, 2.5 and 32.5 % (P 
less than 0.01 and P less than 0.001). In this study, penicillin resulted in a 
decreased incidence of alveolitis. 
In the latest review article (Antibiotic prophylaxis for dentoalveolar surgery: is it 
indicated), Lawler (2005) states that there are no randomized controlled clinical 
studies of antibiotic prophylaxis for dentoalveolar surgery, including third molar 
removal and dental implantation. Other less rigorous studies show conflicting or 
equivocal results. 
This literature review has attempted to evaluate the use of antibiotic therapy for 
third molar surgery. The incidence of postoperative infection ranges from 1% to 
less than 6% (Peterson, 1990; Laskin, 2003), with most of those being minor 
infections. This low complication rate would not support the routine use of 
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antibiotic prophylaxis if you follow the basic principle of prophylaxis. In addition, 
the potential for adverse reaction to antibiotic therapy exceeds any possible 
decrease in infection. Studies that have compared infection rates after use or 
non-use of antibiotics do not show decreased infections in the antibiotic groups.  
The literature review would support a study to assess the value of prophylactic 
antibiotic in third molar surgery. The objective of this study was to establish 
specific guidelines for prophylaxis in third molar surgery for the department of 
Maxillo-Facial and Oral Surgery at Tygerberg Academic, Groote Schuur and 
Mitchells Plain hospitals. 
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CHAPTER 3 
AIM AND OBJECTIVES 
  
Aim: 
 
• To evaluate the potential value of prophylactic antibiotics in third molar 
surgery. 
 
Objectives 
 
• To evaluate the frequency of post-operative complications in third molar 
surgery. 
• To compare the rate of post-operative complications between the two 
groups and a placebo. 
• To recommend specific guidelines for prophylaxis of third molar surgery in 
the department of Maxillo-Facial and Oral Surgery at Tygerberg Academic, 
Groote Schuur and Mitchells Plain hospitals. 
 
Null hypothesis 
 
There will be no difference in post-operative complications in patients with or 
without antibiotic prophylaxis in third molar surgery. 
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Rationale 
 
• Third molar surgery is a common surgical procedure. Antibiotic 
prophylaxis in third molar surgery is the debate of the day and its use is 
controversial. 
• The motivation for the study comes from the number of patients who go 
through third molar surgery every year. 
• This research is relevant in that it will set guidelines for antibiotic 
prophylaxis in third molar surgery for Maxillofacial and Oral Surgery 
department at Tygerberg Academic, Groote Schuur and Mitchells Plain 
hospitals for the management of their patients. 
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CHAPTER 4 
MATERIALS & METHODS 
 
4.1. Study Methodology 
4.1.1 Study Design: 
The study was a prospective, randomized, double blind, placebo-controlled 
clinical trial in which the patients acted as their own control (cross over). They 
were randomly assigned into two groups. Two third molars were removed under 
antibiotic cover and the other two were removed without antibiotic cover. 
Neither patient nor surgeon was aware which teeth were removed under 
antibiotic cover. The exact nature of the medication was not revealed to the 
patients or surgeon. The capsules were of same shape, size and color and were 
filled with either antibiotic or placebo. Randomization was conducted by the well-
trained hospital nursing staff during the entire period of the double blind study. 
 
4.1.2. Study population: 
 
Patients with four impacted third molars on waiting list for third molar surgery, at 
Oral Health Centre, Tygerberg Academic Hospital, were included in the study 
 
4.1.3. Sample Size 
 
One hundred patients with four impacted third molar were invited to take part in 
the study. The patients were paired using radiographs and the Pell and Gregory 
classification and then assigned to two groups. Each patient acted as its own 
control. 
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4.2. Methodology 
 
Group- I received 1 gm of amoxicillin, 1 hour before surgery (pre-operatively) 
only on the first surgical visit. On the second surgical visit placebo capsules 
(capsules of same shape and size with glucose in it) were given or vice versa. 
 
Group-II received 1 gm of amoxicillin, 1 hour before surgery and then 500 mg 
8 hourly for two days (the current regimen) on the first surgical visit. On the 
second surgical visit placebo capsules (capsules of same shape and size with 
glucose in it) were given or vice versa. 
 
Prior to the trial, each patient was informed about the study, its aim, implications 
and possible complications. Signed informed consent was obtained. The patients 
were examined clinically and those with infections or on antibiotics were 
excluded. The angulations and depth of the third molars were recorded from the 
pantomograph using the Pell and Gregory. The Pell and Gregory system classifies 
the relative depth of impaction on the basis of its vertical relationship to the 
second molar and the ramus. 
 
Surgery was carried out under local anaesthesia using a standard operative 
technique for all patients. 
 
4.2.1. LOCAL ANESTHESIA (LA) 
 
The inferior dental (inferior alveolar nerve and long buccal blocks) as well as 
local infiltration are the main stay of LA in mandibular third molar surgery. The 
aim is to deposit the LA solution around the inferior alveolar nerve as it enters 
the mandibular foramen at the lingula. The long buccal nerve was anaesthetized 
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by injecting 0.5-1 ml of LA posterior and buccal to the last molar tooth. For the 
maxillary buccal and palatal infiltration anaesthesia was used.  
 
4.2.2. SURGERY 
Surgery was performed by raising an envelope mucoperiosteal flap. If indicated, 
bone was removed on the buccal and distal aspect of the third molar with a no 8 
round surgical burr under constant sterile 0.9% saline irrigation. Tooth elevation, 
crown removal and or root division and elevation were done as required. After 
removal of the tooth the surgical field was meticulously rinsed with sterile 0.9% 
saline. The wound was closed by placing 3-0 Vicryl® interrupted sutures.  
 
A standard regime of analgesics (ibuprofen 400mg pre-operatively, ibuprofen 
400mg 6-hourly for 2 days) plus paracetemol 500mg and codeine phosphate 
8mg 6-hourly for 2 days) was used. A mouthwash (0.2% chlorhexidine gluconate 
10ml stat, pre-operatively and 8-hourly for 3 days), was given to all patients. 
Tilidine-HCl, (50mg) was used as an escape analgesic (maximum three 
capsules). 
 
4.2.3. PATIENT SELECTION 
Inclusion criteria 
1- American Society of Anesthesiologists (ASA) Class I patients between 17-
40 years of age and gender, and race  
2- Patients with four impacted third molars 
 Exclusion criteria 
1- Patients with active pericoronitis or infection 
2- Blind patients as they can not use a Visual Analogue Scale 
3- Patients with blood dyscrasia or using anticoagulants 
4- Patients with rheumatic heart disease 
5- Patients with associated third molar pathology  
 
 
 
 
 - 36 -
6- Patients using homeopathic or alternative medication for any reason 
7- Immunocompromised patients 
8- Mentally challenged patients 
9- Patients who have used antibiotics in the past 14 days 
10-Patients allergic to penicillin  
 
4.2.4. CRITERIA FOR EVALUATION 
 
Pain 
To allow a continuous assessment of pain, visual analogue scale uses a 10 cm 
line labeled at ‘0’ with ‘no pain’ and ‘10’ with ‘worst’. The line is marked at a 
point corresponding to the assessment of the pain. The distance of the mark 
from zero is measured. 
 
In this study, pain severity was recorded on a Visual Analogue Scale (VAS). Pain 
was recorded three times a day for two weeks. Patients were instructed to rate 
and record pain intensity on the VAS.  
 
Pain 
Variables                  Score 
None       0 
Mild       1 
Moderate      2 
Severe      3 
Could not be worse     4 
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Figure-4.1 Visual analogue scale/graphic rating scale 
 
 
Swelling  
Swelling was measured pre-operatively, after 3 days, 7 days and after two weeks 
post-operatively. 
 
Variables         Score 
None (absent)   0 
Mild (just visible and palpable) 1 
Moderate (obvious)               2 
Severe             3 
 
 
Trismus (in mm) 
Maximum mouth opening ability was measured in millimeters between the upper 
and lower right central incisors using Vernier-calibrated sliding calliper pre-
operatively, and on every visit. 
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Trismus (Difference in mouth opening in mm) 
Variables           Score 
                                    Non                          0 
1-5 mm             1 
6-10 mm    2 
                                    11-15 mm  3 
16-20 mm    4 
>20 mm    5 
 
 
Temperature (> 38 ° C) 
 
Temperature was recorded pre-operatively and on every visit.  
Temperature >38°C was considered a fever. 
 
Temperature  (>38°C) 
Variables                  Score 
No               0 
                                    Yes (>38° C)            1 
 
Pus collection and/or discharge 
Clinical signs of pus collection were recorded on every visit. 
 
Clinical collection of pus 
Variables         Score 
None   0 
Yes   1 
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Dry socket 
Patients were evaluated for dry socket at each visit, halitosis, pain, clinical signs 
of clot less socket with necrotic bone were used as diagnostic criteria. 
 
Dry socket 
Variables          Score 
None                       0 
Yes            1 
 
The Pell & Gregory Classification 
 
In 1923 Pell and Gregory demonstrate on tooth division technique for the 
removal of impacted teeth. Ten years (1933) later, they published their first 
article in which they also classified the third molar impactions into different 
groups i.e. according to the relation of the tooth to the ramus of the mandible, 
relative depth of the third molar in the bone. They also demonstrate the position 
of the third molar in relation to the long axis of the second molar using Winters’ 
classification.  
 
Relative depth of the third molar in the bone 
Depth A 
The occlusal plane of the impacted tooth is at the same level as the occlusal 
plane of the second molar. 
Depth B 
The occlusal plane of the impacted tooth is between the occlusal plane and 
cervical line of second molar. 
Depth C 
The impacted tooth is below the cervical line of second molar. 
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According to the relation of the tooth to the ramus of the mandible 
Class I 
There is sufficient space between the ramus and the distal part of second molar 
for accommodation of the mesio-distal diameter of the third molar. 
 
Class II 
The space between the second molar and the ramus of the mandible is less than 
the mesiodistal diameter of the third molar. 
 
Class III 
All or most of the third molar is in the ramus of the mandible. 
 
4.3- Ethical Considerations 
• This proposal was approved by the Research and Ethics Committee of the 
University of the Western Cape 
• Participation in this study was on voluntary basis  
• Patients were adequately informed about the objective of the trial 
• Written informed consent was obtained from every patient  
• Patients with any other dental problems were referred to the appropriate 
departments 
• Participants had the right to withdraw from the study at any stage and 
this would not prejudice them in  regard to future treatments 
• The rights of patients were protected at all times 
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4.4- Data management and statistical analysis 
The data was tabulated on an excel spreadsheet and was analyzed using a 
commercially available statistical software package (SPSS 15.0, SPSS Inc.). 
Original data was supplied to the statistician. 
 
• The Chi square test was used to compare the proportion of the nominal 
variables among the two treatment groups 
• Fisher's Exact Test 
• Non-parametric analysis of variance was used to identify any significant 
variables in the two groups  
 
4.5- Budget 
 
• Statistical analysis       R 8,000 
• Drugs        R 2,000 
• Research assistants      No cost 
• Miscellaneous(Printing,papar)    R 5,000  
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CHAPTER 5 
RESULTS 
 
5.1. DEMOGRAPHIC CHARACTERISTICS 
 
Hundred patients (62 females and 33 males) were included in the study. Mean 
age of the study population was 26 years ( range 17 to 37). Surgery was 
performed on 100 patients but only 95 patients completed the study protocol 
(five patients left the study because of their personal reasons). 
 
Three hundred and eighty impacted third molars were removed from the two 
groups(192 in group I and 188 in group II). There was no significant difference 
between the two groups in regard to degree of eruption, degree of impaction or 
difficulity of removal. 
 
5.2. IMPACTIONS ACCORDING TO THE CLASSIFICATION SYSTEMS 
 
A total of 138 bony (Class II & III) impacted mandibular third molars and 75 
maxillary bony (Class II & III)  impacted third molars were removed in the study. 
Fifty three Class I mandibular third molar impactions and 115 impacted maxillary 
third molars were removed.  
 
In the maxilla, 62 impacted third molars were below the cervical margin of the 
second molar, while only 6 impactions in the mandible were below the cervical 
margin of the second molar. There were 107 vertical impactions in maxilla 
compared to 32 in the mandible. 
 
 
 
 
 - 43 -
 
No horizontal impactions were found in maxilla but 13 impacted third molars 
were horizontally impacted in the mandible. Mesio-angular impactions in the 
mandible showed the same patern. There were 73 mesioangular impactions in 
the mandible and only 23 in the maxilla. 
 
5.3. INFECTION PREVALENCE IN THE TWO GROUPS 
 
The association between the use of antibiotic therapy and tested variables was 
evaluated by using the Chi square test and the Fisher exact test as shown in 
table I & fig 5.1. Multiple logistic regressions was used in order to identify the 
variables useful in predicting pain, swelling, trismus, clinical collection of pus and 
dry sockets. 
 
Only 6 post-operative infections were recorded in 380 sockets. In group I [one 
dose of antibiotics (1 gm) only and control], three infections were recorded of 
which  two were in the placebo group and one in the stat group. No infection 
was recorded on the 7th and 14th day of surgery in this group. One infection was 
recorded three weeks after surgery in the placebo group (table II).  
 
In group II, only 2 infected sockets were recorded. One patient was on 
antibiotics and the other on placebo capsules. Both of these infections were 
recorded on the 3rd day after surgery. It is interesting to note that both the 
infections occurred on the same patient. 
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Table I – Infections in different treatment groups at day 3 of surgery 
 
 
Infection day 3 
Treatment Group No (%) Yes (%) 
One dose of 1gm only 97.9 2.1 
Placebo of group I 95.8 4.2 
Two days of antibiotics 97.9 2.1 
Placebo of group II 97.9 2.1 
Total 97.4 2.6 
 
                 Table I shows the occurrence of infection after 3 days of surgery in the treatment groups 
 
 
 
Number of infections on day 3 of surgery
2
1
1 1
One dose of 1gm only Placebo of group I
Two days of antibiotics Placebo of group II
 
 
Figure- 5.1 Total number of infections in the treatment groups on 3rd day of surgery 
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Table- II Treatment Group I & II Infection day 7 
 
Infection day 7 
Treatment Group No (%) Yes (%) 
One dose of 1gm only 100 0 
Two days of antibiotics 97.9 2.1 
Total 98.9 1.1 
 
 
Table II shows prevalence of infection in the two treatment groups after seven days of surgery. No infection 
was found in group I compared to one in group II.  
 
 
 
5.4. Post-Operative Swelling 
Swelling on the 3rd day after surgery 
 
Group I 
In group I,  37 patients presented with no swelling , 5 patients had mild and only 
one patient  presented with severe swelling. In the placebo group 18 patients 
had no swelling, while 15 patients showed mild and moderate swelling on the 
third day after surgery. 
 
Group II 
Twenty two patients in group II had no swelling. Eighteen patients presented 
with mild swelling and only one patient with severe swelling. Swelling acording to 
the classification system are shown in fig 5.2 and 5.3. Twenty patients of the 
pacebo subgroup presented with mild swelling and 10 with moderate swelling on 
the third day after surgery. Two patients had severe swelling in this group. 
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Figure- 5.2 Relationship of swelling to the type of impaction 
 
 
 
Relationship of Swelling to type of impaction 
(mandible)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
On day 3 of surgery On day 7 of surgery On day 14 of surgery
Time Factor
Sc
or
e 
of
 S
w
el
lin
g
Class I
Class II
Class III
 
 
    Figure- 5.3 Swelling in relation to time in different treatment groups 
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Swelling on 7th and 14th day after surgery 
 
Forty two patients in group I and 36 patients in group II presented with no 
swelling on the 7th day after surgery. Five patients in group I and 9 patients in 
group II presented with mild swelling on the 7th  day after surgery. Thirty seven 
patients in placebo group I and 32 patients in placebo group II had no swelling 
(Fig 5.4).  
 
Three patients in placebo of group II developed severe swelling on the 3rd day 
after surgery. Placebo of group I showed no swelling on the 14th day after 
surgery. Four patients in group II (placebo) presented with mild  swelling on 14th 
day after surgery as shown in fig 5.5 and 5.6. 
 
In group I and group II, the results indicate that there is a significant time effect 
(p< 0.001). This means that the swelling score changes over time i.e. swelling 
score decreased with the passage of time. The results also indicate that there is 
a significant time treatment group interaction (p < 0.05). However, there is no 
significant evidence of treatment group effect (p > 0.05). Thus, the swelling 
scores in the two treatment groups are not statistically different i.e. p value 
>0.05. 
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                      Figure-5.4 Relationship of swelling to days in the two groups 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Day 3 Day  7 Day 14
Days
M
ea
n 
of
 s
w
el
lin
g 
sc
or
es
One dose of 1gm
Placebo of group 1
 
Figure- 5.5 Relationship of swelling to days in group I 
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                 Figure– 5.6 Swelling among the placebos of two treatment groups (I & II) 
 
 
 
5.5. PREVALENCE OF “DRY SOCKETS”   
 
Only one patient from Group I presented with a dry socket on the 7th day after 
surgery. 
 
5.6. ADVERSE REACTIONS TO MEDICATIONS 
 
No adverse reactions were found in the study. A few patients had minor 
complaints of constipation. This is a side-effect of codein phosphate.   
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5.7. TRISMUS 
Trismus on the 3rd day after surgery 
 
Group I 
Eleven patients in this group showed no difference in maximum mouth opening 
before and after the surgery. Only 3 patients presented with severe trismus on 
the 3rd day after surgery. In the placebo of the same group, 10 patients had no 
trismus and 6 patients presented with severe trismus 3 days after surgery. 
 
Group II 
In the antibiotic group only 2 patients had no difference in the maximum mouth 
opening before and after surgery. Four patients had maximum trismus on the 3rd 
day of surgery. One patient in the placebo sub group, showed no signs of 
trismus and 6 patients had severe trismus on the 3rd day of surgery (fig 5.7).  
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Figure- 5.7 Relationship of maximum mouth opening to time 
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Trismus on the 7th and 14th day after the surgery 
 
Group I 
Two patients had severe trismus on the 7th day while 32 patients remained 
trismus free. On the 14th day, only one patient documented mild trismus. In the 
placebo of group I, 25 patients had no trismus and only 1 patient showed severe 
trismus on the 7th day. Five patients of placebo of this group showed mild 
swelling. 
 
Group II 
Only one patient in the group II presented with severe trismus on the 7th day 
while 11 patients showed mild trismus on the 14th day after surgery. In the 
placebo of the same group only one patient showed severe trismus on the 7th 
day while 14 patients had with mild trismus on the 11th post-operative day.  
 
The results indicate that there is a significant time effect (p< 0.001) as shown in 
table VIII. This means that the trismus scores change over time. The results also 
indicate that there is a significant time and class interaction (p < 0.05). While the 
trismus scores in class I and class II are not significantly different (p > 0.05), 
these results suggest a significant difference between class I and class III as well 
as between class I and class III (p < 0.05) as shown in fig 5.8 and 5.9.  
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Figure- 5.8 Relationship of trismus to days in mandibular teeth according to level of 
impaction 
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Figure- 5.9 Relationship of trismus with time in impacted third molars according to 
Pell and Gregory classification 
 
 
 
 
 - 53 -
The results shows that there were time effect (p-value<0.001) and pain changes 
over time. No statistically significant difference was found between the two 
treatment groups (p-value >0.05) after applying repeated measure analysis of 
variance as shown in figure 5.10. 
 
  
           Figure- 5.10 Pain with time factor in the different treatment groups 
 
5.7. Paresthesia after surgery 
Among the 95 patients, only two (one in group I & II respectively) patients 
presented temporary inferior alveolar paresthesia. Paresthesia in both patients 
was recovered within two weeks post-operatively. 
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CHAPTER 6 
DISCUSSION 
 
 
The findings in this study were based on periodical clinical examinations. As 
anticipated, there was a good correlation between the patients’ own assessments 
of pain on a VAS with the difficulty of impacted third molar. Most patients, who 
reported swelling, also had impaired mouth opening (Trismus). 
 
The methods we used to evaluate pain, swelling, trismus and infection are 
described in the literature. Inter-examiner variability was excluded by using only 
one research assistant. All assessments were done in the same clinical 
environment. 
 
Post-operative infection of bone and soft tissues is a common complication that 
can be reduced with good surgical techniques. Some bacterial contamination of a 
surgical site is inevitable, either from the patient’s own bacterial flora or from the 
environment. Antibiotics are commonly administered prophylactically for major 
and minor surgical procedures. In many cases, antibiotics are prescribed only 
after the procedure. No intra-operative antibiotic cover is thus achieved which is 
in conflict with the basic principles of prophylaxis. 
 
In 1970 Paterson and his colleagues questioned the value of prophylactic 
antibiotics in third molar surgery. Nordenram et al (1973) used Neomycin cones 
in impacted third molar sockets and found them useful to prevent postoperative 
complications and infection. Later, in 1974 Curran et al, in a double blind study, 
concluded that the use of prophylactic antibiotics in third molar surgery was 
 
 
 
 
 - 55 -
unnecessary unless specific systemic factors were present. In 1976, Laskin urged 
hospital oral surgery departments to establish specific guidelines for prophylaxis 
and treatment. Thirty years later, Poeschl et al (2004) in his randomized 
controlled trial, concluded the same results as those of Curran in 1974. 
 
There was growing concern in the department of Maxillo-Facial and Oral surgery 
at University of the Western Cape about the misuse of antimicrobials in the 
removal of wisdom teeth. Therefore it was decided to investigate the value of 
antibiotics in third molar surgery. 
 
Early studies led to the recognition that reducing the amount of bacteria in the 
wound lowers the infection rate. Prophylaxis is aimed at a reduction of surgical 
site infection (SSI) by preventing local growth of potential pathogens in the 
tissues. Prophylaxis is mainly shown to be effective in reducing incisional surgical 
site infections. A significant lowering of the incidence of SSI results in several 
advantages: 
• Decrease of post-operative stay 
• Decrease in therapeutic use of antimicrobial drugs thereby minimizing 
adverse affects of antimicrobials 
• Cost containment benefits 
[Guideline for prevention of surgical site infection 1999, (Alicia J, et al 1999)] 
 
It is important to emphasize that surgical antibiotic prophylaxis is an adjunct to 
and not a substitute for good surgical technique. Antibiotic prophylaxis should be 
regarded as one component of an effective policy for the control of hospital-
acquired infections. 
 
There have been a large number of studies of surgical prophylaxis to provide 
scientific evidence to guide clinicians as to the surgical indications, choice, route, 
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and duration of antibiotic prophylaxis, and a number of guidelines have been 
published on this topic (Mangram et al, 1999). 
 
In this study we followed the guidelines of surgical wound prophylaxis by using 
antibiotics 1 hour pre-operatively. 
  
Pallasch (2003) in his article, mentioned that “No clinical studies have adequately 
document the efficacy of peri-operative (begun before and stopped shortly after 
the surgery) antibiotic prophylaxis in the prevention of orofacial infection”. 
 
In this study we used two groups, group I with single loading dose of one gram 
of antibiotics only and group II with one stat dose of antibiotics plus two days 
regimen, by using the split mouth technique in which each group acted as its 
own control. We are convinced that such a randomized controlled trial has never 
been implicated earlier to evaluate the efficacy of antibiotic prophylaxis in third 
molar surgery.  
 
Most odontogenic infections are poly-microbial and are composed of at least two 
predominating bacteria, commonly streptococci, anaerobic gram-positive cocci 
and anaerobic gram-negative rods. Most antibiotic regimens used in 
dentoalveolar surgery fail to meet the key criteria of surgical prophylaxis (Burke, 
1961; Stone et al, 1979). Jaunay et al in 2000 mentioned that most of the 
antibiotics are prescribed in relatively low dose over a long period.  
 
Penicillin is still the gold standard in treating dental infections. Penicillin has 
contributed to a dramatic decrease in mortality in serious odontogenic infections 
such as Ludwig’s angina and diffuse orofacial cellulites (James & Wendy 2003). 
 
One of the aims of rationalizing surgical antibiotic prophylaxis is to reduce the 
inappropriate use of antibiotics thus minimizing the consequences of misuse. 
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Rates of antibiotic resistance are increasing in all hospitals (Gold and Moellering, 
1996). The prevalence of antibiotic resistance in any population is related to the 
proportion of the population that receives antibiotics, and also the total antibiotic 
exposure (McCaig and Hughes, 1995).  
 
An additional problem is the dramatic increase in the number of cases of colitis 
caused by clostridium difficile. The prevalence of clostridium difficile infection is 
related to total antibiotic usage and in particular, to the use of 3rd generation 
cephalosporins. In epidemiological studies of clostridium difficile colitis, surgical 
antibiotic prophylaxis is the single most common indication for use of antibiotics 
(Jobe et al, 1995).  
 
In a study, Namias et al has shown a statistically significant increase in the 
frequency of bacteraemia and infections in surgical patients who received 
prophylactic antibiotics for more than four days in comparison with those who 
received prophylaxis for one day or less (Namias et al, 1999). 
 
Side effect most often encountered is penicillin hypersensitivity, which is found in 
roughly 3-5% of the population. Anaphylactic reactions occur in 0.04-0.011 
percent of patients receiving penicillin for prophylaxis. Gastrointestinal tract 
upset, colonization of resistant or fungal strains, cross reactions with other drugs 
and other allergies, are also associated with antibiotic therapy. 
 
Because of their ineffectiveness against the oral anaerobes, macrolides are no 
longer considered among the empiric antibiotics of choice for odontogenic 
infections (Flynn and Halpern, 2003). On the other hand penicillin resistance has 
not been shown to be a significant problem in outpatient odontogenic infections. 
 
In this study we excluded patients who were allergic to penicillin. Four patients 
of the study sample presented with infection on the third day after surgery and 
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two patient presented infection after three weeks (late infection). We recorded 
four infections in placebo group and two infections in the antibiotic group. These 
infections were managed by incision, drainage and rinse with normal saline. A 5 
day course of antibiotics (amoxicillin, 500mg caps 8 hrly and metronidazole 400 
mg tabs 8 hrly) were prescribed. The patients were symptom free after 48 hours. 
No adverse reactions of antibiotics were found in 95 patients. 
 
The final decision regarding the benefits and risks of prophylaxis for an individual 
patient will depend on: 
• The patient’s risk of surgical site infection 
• The potential severity of the consequences of surgical site infection 
• The effectiveness of prophylaxis in that operation 
• The consequences of prophylaxis for that patient (e.g. increased risk of 
colitis) 
 
The period for surgical site infection begins at the time of incision. The time 
taken for an antibiotic to reach an effective concentration in any particular tissue 
reflects its pharmacokinetic profile and the route of administration (Martin, 
1994). Administration of prophylaxis more than three hours after the start of the 
operation, significantly reduces its effectiveness. Classen et al suggested that in 
order to obtain maximum effects, it should be given just before or immediately 
after the start of the operation (Classen et al, 1992).  
 
Prophylaxis should therefore be confined to the peri-operative period (i.e. 
administration immediately before or during the procedure). Post-operative 
doses of antibiotic for prophylaxis should not be given. Any decision to prolong 
prophylaxis beyond a single dose should be explicit and supported by evidence 
based protocols. 
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Out of 380 impactions, only six sockets become infected and there was no 
statistically significant difference between the two groups (I & II), i.e. p value 
>0.05. Infection rate was 1.57% which demonstrates that third molar surgery is 
a clean contaminated surgical procedure as described by Peterson in 1990.  
 
A number of reports during the past few decades have dealt with the use of 
antibiotics in third molar surgery. Researchers used different antibiotic regimens. 
Most researchers used amoxicillin, metronidazole, clindamycin, cephradine, 
tinidazole / pivampicillin, clvulanic acid and doxicycline (Falconer, 1992; Gill and 
Scully 1988). They found infection rates ranging from 1.0% to 27% (Lawler, 
2005). However, over all incidence of infection from third molar extraction has 
been reported to be in the range of 3% to 5% (Osborn et al, 1985; Goldberg et 
al, 1985; Susarla et al, 2003). 
 
It has been suggested by Osborn et al (1985) that the rates of post-operative 
infection are higher for mandibular bony impactions than for any other type of 
extractions, as result of increased trauma. Surgical experience can also influence 
the rate of secondary infection (Osborn et al 1985; Sisk et al, 1986). 
 
The overall results of the present study corresponded well with those previously 
reported by Sisk et al, 1986; Christiaens and Reychler, (2002) with respect to 
infection and other complications. 
 
In their study in 1987, Mitchell and Morris reported late infections in third molar 
surgery i.e. 4-6 weeks after the surgery. Other studies showed same delayed- 
onset infection rates such as Goldgerg et al (1.8%), Piecuch et al (1.8%) and 
Figueiredo et al (1.5%).  
 
In the present study, three sockets in two patients presented with delayed onset 
infection after 3 weeks. One patient was on placebo medication and the other 
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patient presented infection on both the occasions (on first surgical visit with 1 
gm of antibiotics and then 500 mg 8 hrly for two days and on second surgical 
visit on placebo capsules). The overall delayed-onset infection rate (0.78%) in 
the presented study correlates with the literature as discussed earlier. 
 
Dry socket is one of the most common complications associated with third molar 
surgery. The overall rates of alveolar osteitis vary in the literature from 1% to 
30%. The variability of reported percentages can be attributed largely to 
ambiguous diagnostic criteria (Susarla et al, 2003). Mandibular third molar 
surgery is more commonly associated with alveolar osteitis than maxillary third 
molar surgery. 
 
Numerous studies supported that increasing age, female gender, oral 
contraceptives, smoking, surgical trauma and pericoronitis as risk factors for 
alveolar osteitis, although a significant number of studies also refuted these 
associations (Alexander, 2000). Sekhar (2001) and Bergdahl (2004) in their 
prospective studies compared systemic peri-operative use of metronidazole with 
placebo and found that the incidence of alveolar osteitis and early post-operative 
infection to be the same in both groups. Reekie et al (2006) in his double blind 
study, found no significant difference between the metronidazole and placebo 
groups. 
 
Sanchis et al (2004) used tetracycline compound to prevent dry socket and 
concluded that intra-alveolar placement of tetracycline compound after the 
removal of impacted mandibular third molars did not affect the incidence of dry 
socket. Nordenram (1973) found that intra-alveolar tetracycline/neomycine-
bactracin cones significantly reduce pain and alveolar osteitis (Nordenram, 
1973). 
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In the present study only one patient developed alveolar osteitis (0.52%) after 
mandibular third molar removal. The patient was a 24 year old medical student. 
He had a disto-angular impaction which was removed without any complications. 
On further investigation, he mentioned that he used an excessive mouth rinse on 
the day of surgery. 
 
Swelling is an expected sequela of the 3rd molar surgery. It reaches a maximum 
level 2 to 3 days post-operatively and normally subsides by the 4th day. It should 
completely resolve by the 7th day post-operatively. The use of cryotherapy or 
cold therapy is still controversial. Laureano et al (2005) supported the 
cryotherapy and found it effective in reducing swelling and pain. The study was 
done only on 114 patients, but results were statistically not significant. 
 
Van der Westhuijzen and Morkel (2005) evaluated 60 patients in their 
randomized observer blind comparison of facial ice pack therapy with no ice 
therapy following third molar surgery. They found no statistically significant 
difference between the two treatment groups with respect to pain, facial swelling 
and trismus.  
 
In a recent study (Master’s mini thesis) at the same institution, the use of 
chewing gum therapy to reduce swelling after third molar surgery was 
researched. No significant difference between the chewing gum user and non 
user was found. 
 
In the present study, we compare swelling in the two treatment groups. In the 
case of groups I and group II, the results indicate that there is a significant time 
effect (p< 0.001). This means that the swelling score changes over time. The 
results also indicate that there is a significant time treatment group interaction (p 
< 0.05). However, there is no significant evidence of treatment group effect (p > 
0.05). Thus, the swelling score in the two treatment groups are not significantly 
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different as shown in the tables. These results are similar to those of Curran et 
al, (1974), Monaco et al, (1999) and those of Lloyd (1994). 
 
Pain after third molar surgery usually begins when the effect of anesthesia 
subsides. It reaches its peak at 6 to 12 hours post-operatively. The effective 
manage pain management is regarded as an essential skill of the prudent 
surgeon. Preoperative systemic analgesics reduce pain by inhibition of central 
and peripheral pain receptors. Prophylactic analgesic therapy is intended to 
inhibit the effects of the surgery on the surrounding tissue. 
 
The first drug to consider for pain is paracetamol (acetaminophen). It is 
indicated for the management of mild to moderate pain. Its favorable risk/benefit 
balance makes it a popular choice for acute postoperative dental pain. 
 
Bjørnsson et al (2003) in his randomized, double blind, controlled, cross over 
study of 36 patients, concluded that a three days regimen of ibuprofen (600 mg 
6 hourly) does not offer any clinical advantages compared with a traditional 
paracetamol regimen of 1000 mg, 6 hourly, for acute postoperative swelling and 
pain after third molar surgery. But the low number of patients used for the 
study, did not produce statistically significant results.  
 
Paracetomol in combination with an opiate is an extremely effective analgesic 
(Comfrot et al, 2002 and Hargreaves, 2005).  Non steroidal anti-inflammatory 
drugs (NSAIDS) are proven potent anti-inflammatory/analgesic drugs for acute 
pain (Haglund, 2006) and are widely used for third molar surgery. 
 
Most painful problems that require analgesics will be due to inflammation. Pain 
management drugs include non-narcotic analgesics (e.g., non-steroidal anti-
inflammatory drugs, paracetamol) or opiates (i.e., narcotics). Non-steroidal anti-
inflammatory drugs (NSAIDs) provide excellent pain relief due to their anti-
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inflammatory and analgesic action. The most common NSAIDs are asprin and 
ibuprofen. Paracetamol gives very effective analgesia but has little anti-
inflammatory action. The opiates are powerful analgesics but have significant 
side effects. They are used in combination with paracetamol (Comfort et al, 
2002; Hyllested et al, 2002). 
 
In this study we used combination of analgesics and NSAIDS (i.e. ibuprofen, 
paracetamol and codine). We planned to give tilidine HCl as the escape oral 
opiate analgesic, but it was never needed. 
 
The results shows that there were time effect (p-value<0.001) and pain changes 
over time. No statistically significant difference was found between the two 
treatment groups (p-value >0.05) after applying repeated measure analysis of 
variance as shown in the graph. These results correlate with those of Curran and 
Sekhar who also found no statistical significant difference between the antibiotic 
group and placebo to prevent infection after third molar surgery. 
 
Trismus is often the result of surgical trauma. It is secondary to masticatory 
muscle and facial inflammation. Trismus is the body’s attempt to prevent 
additional trauma or pain after third molar surgery (Rowe, 1982). Recognized 
regimens for treating trismus include ultrasonic therapy, pharmaco-therapeutics 
and cryotherapy. 
 
In this study we found no statistical significant between the two treatment 
groups regard trismus (p-value >0.001). But there is significant differences 
between the class of impaction (p-value <0.05) i.e. in class III the patients 
suffered more trismus than those with class I and I. There is significant 
difference between low level impaction (depth C) and high level impaction (depth 
A) for trismus as shown in the graphs below. 
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Injuries to the inferior alveolar and lingual nerve are well recognized 
complications of third molar surgery. Sisk et al, (1986) mentioned the prevalence 
of damage to lingual and inferior alveolar nerve after third molar surgery to be 
from 0.04% to 22% (Sisk et al, 1986). In the majority of the review cases, 
paresthesia was found to be temporary and tends to subside within the first six 
months (Osborn et al, 1985). 
 
The incidence of neurologic injuries from third molar surgery is related to 
multiple factors, including surgeon experience and proximity of the tooth relative 
to the inferior alveolar canal. Horizontally impacted teeth are generally more 
difficult to remove because of the increased need for bone removal and soft 
tissue manipulation when compared with distoangular or mesioangular 
impactions with higher incidence of nerve damage (Mostapha et al, 2001; Brann 
et al, 1999). 
 
In the current study, only two patients, one from each group presented with 
neuropraxias (Seddon first degree injury). In group I, a 30 years old female with 
mandibular distoangular impaction showed signs of temporary dysesthesia. 
These symptoms subsided within two weeks. In group II, the patient had 
mandibular horizontal impaction, he also showed temporary dysesthesia, but the 
recovery was rapid and he took only four days to recover.  
 
In this study, overall temporary nerve damage rates were 0.52%, which 
correlates the literature (Goldberg et al, 1985; Gülicher and Gerlach, 2001; 
Renton, 2001). 
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CHAPTER 7 
LIMITATIONS OF THE STUDY  
 
 
It was difficult to get the patients compliance because of the number of follow 
up visits as every patient has to come for follow up 8 times including the day of 
surgery. Five patients were unable to complete the follow up visits because of 
their domestic/financial conditions or other engagements.  
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CHAPTER 8 
CONCLUSIONS AND RECOMMENDATIONS 
 
The results of the study showed that the prophylactic antibiotics do not have 
statistically significant effects on post-operative infections. Therefore, there is no 
justification for using antibiotics routinely for third molar surgery. However, we 
need a safe and effective analgesic and anti-inflammatory combination after third 
molar surgery to prevent post-operative pain. 
 
From the results of our study we believe that single dose pre-operative 
prophylaxis is a safe way to minimize the infection rate and costs in the hospital 
setting. 
 
Complications invariably occur following the surgical removal of third molars. 
Attention to the basic principles of surgery, including proper preparation of the 
patient, asepsis, hemostasis, use of controlled force, thorough debridement, and 
meticulous management of both bone and soft tissues can reduce the number 
and severity of complications. 
 
It is important to emphasize that surgical antibiotic prophylaxis is an adjunct to, 
not a substitute for good surgical technique and efforts to control overuse of 
antibiotics should be pursued. 
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Appendix-1 
Department of Maxillo-Facial and Oral Surgery 
Faculty of Dentistry& WHO Oral Health Collaborating Centre 
University of the Western Cape 
Cape Town 
April, 2006.                                                                               (Appendix-1) 
Patient Information Letter 
Currently most doctors gave antibiotics before and after tooth removal (extraction), to 
prevent infection before it occurs. We all know, antibiotics can be harmful to the body. 
There is not much literature to support antibiotic usage before and after tooth removal. 
The department of Maxillo-facial and Oral Surgery (University of the Western Cape) 
Oral Health Centre and the Medical Research Council (MRC) is conducting a study 
(experiment / research) on the use of antibiotics to prevent infection in third molar 
surgery. 
The aim of the research is to determine whether it is useful to give antibiotics after tooth 
removal (third molar surgery) or not .All patients taking part in the study will benefit 
from the treatment. 
Two wisdom teeth will be removed under antibiotic cover and two will be removed 
without antibiotic cover.  Neither patient nor surgeon will know which teeth were 
removed under antibiotic cover. It will therefore be possible to determine whether 
antibiotics are useful or not. 
After the surgical procedure patients will receive tablets/ capsules. The exact nature of 
the medication will not be revealed (The capsule will be of same shape and size but will 
have active content (Antibiotic) or just glucose in it). Willing participants in this study 
will be required to sign a consent form. 
 As a large number of patients are required for this study, it would be appreciated if 
participants enrolling for the study see it through to completion. 
 
Thanking you in anticipation. 
 
 
 Prof J.A.Morkel                   Dr A. Siddiqi 
Department of Maxillofacial & Oral Surgery.    Researcher 
Oral Health Centre Tygerberg. 
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Appendix-2 
Consent form 
Department of Maxillo-Facial and Oral Surgery 
           Faculty of Dentistry& WHO Oral Health Collaborating Centre 
                                               University of the Western Cape 
                                                                  Cape Town 
I  Mr/Miss/Mrs.____________Date of birth______________File no: ___________ am 
willing to participate in the above mentioned study. I understand that the study is 
voluntary. I have been informed of the procedure and of the possible complications which 
can occur during and after the procedure. 
I agree to the administration of local anaesthesia and other measures as discussed that 
may be necessary for my comfort, safety, and well being. 
 
I realize that occasionally there are complications with this surgery and the medications. 
The more common complications include pain; swelling; bleeding; difficulty in mouth 
opening; discoloration of the skin; infection; dry socket and temporary numbness and / or 
tingling of the lip, chin, gums, cheek, teeth or tongue. 
In some cases, even with the utmost care there can be stiffness of the neck and facial 
muscles; changes in the bite and temporomandibular joint; nausea; allergic reactions; 
bone fractures; injury to the adjacent teeth  and delayed healing of the wound. 
 
I know that some of the above-mentioned complications can be avoided or reduced by 
carefully following the doctor’s instructions. I have had the opportunity to ask questions 
about the procedure and aspects related to the Study (experiment/ research) and have had 
them answered to my satisfaction.  
This study is approved by the Ethical and Research Committee of the University of the 
Western Cape and participation in this study is on voluntary basis. I am being adequately 
informed about the objective of the trial. I also know that I have the right to withdraw 
from the study at any stage which will not prejudice me in way regarding future 
treatments. My rights will be protected, and all my details will be kept confidential, and 
no details regarding me, personally will be published. 
I hereby consent to the surgery.  
    Patient’s name: ________________                       Signature: ____________ 
    Name of the Witness: ___________                        Signature: _____________      
    Signature of the Researcher._______________ 
                                                                                                              Dr.Siddiqi 
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Appendix-3 
Data capture sheet (Pre-op) 
 
File no ___________          Case no: _________ 
Sex.           M / F           Group: ___________ 
Date of birth: D/ M/ Y/                    Date of operation: ___________                                           
Address/phone______________________________________________    
____________________________________________________________________ 
Teeth to be extracted. ___________                                    
Type of Impaction 
Classification Systems Mandibular Maxillary 
Winter’s classification 
Vertical / Horizontal / Distoangular / Mesioangular. 
  
Pell and Gregory Ramus classification 
Class-I / Class-II / Class-III. 
  
Pell and Gregory occlusal classification 
Level -1/ Level-2 / Lev el-3 
  
 
Inter-incisal mouth opening (mm) 
Preoperatively    _________ 
Swelling  
Preoperatively                     __________ 
Pain (VAS)  
Preoperatively      __________            
Patient will record pain at home for the rest of time (from day 1 to day-14) 
Maximum mouth opening (mm) 
Preoperatively    __________ 
Temperature: (> 38 ° C) 
Preoperatively    ________ 
Infection/ clinical collection of pus        
Preoperatively    _________ 
Adverse reactions to antibiotics (previous experience)                        
GI irritation (diarrhea, vomiting, and nausea) ___________________ 
 Skin reactions, fungal infections, Anaphylaxis 
                                                                                                                      _____________         
Date_______                                                                                                  Dr A. Siddiqi 
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Appendix-4 
Data capture sheet (Day-3, 7 & 14) 
 
File no ___________       Case no: _______      
Group: ___________ 
Teeth extracted ___________ 
Inter-incisal mouth opening (mm) 
On the third day of surgery     _________ 
Swelling  
On the third day     __________ 
Pain (VAS)  
On the third day    __________ 
Patient will record pain at home for the rest of time (from day 1 to day-14) 
Maximum mouth opening (mm) 
On the third day         __________ 
Temperature: (> 38 ° C) 
On the third day        ________ 
Infection/ clinical collection of pus    
 On the third day       _______ 
Dry socket 
 On the third day   _______                
Adverse reactions to antibiotics                          
GI irritation (diarrhea, vomiting, and nausea),            ______________ 
 Skin reactions, fungal infections, Anaphylaxis                                                                                                
                                                                                                            
________________        
 
Date ___________             Dr A. Siddiqi 
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Apendix-5 
Visual Analogue Scale/ Graphic Rating Scale 
 
File no.______                    Teeth extracted_______                    Group______               
Date __________ 
 
 
Day of Surgery   
              Afternoon                                                                         Evening 
 
 
 
 
Day -1  Morning                  Afternoon 
 
 
 
               Evening 
 
 
 
Day - 2 Morning                  Afternoon 
 
 
 
 
            Evening  
 
 
Day -3   Morning                  Afternoon 
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               Evening  
 
 
 
Day -4  Morning                  Afternoon 
 
 
 
  Evening          
 
 
 
Day -5  Morning                  Afternoon 
 
 
 
               Evening 
 
 
 
Day -6  Morning                  Afternoon 
 
 
 
            Evening  
 
 
 
Day -7  Morning                  Afternoon 
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               Evening  
 
 
Day -8  
            Morning                                     Afternoon 
 
 
                             Evening 
 
 
 
Day -9  
                            Morning                    Afternoon 
 
 
 
               Evening 
 
 
 
Day -10   
                        Morning                     Afternoon 
 
 
 
            Evening  
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Day -11 
              Morning                       Afternoon 
 
 
               Evening  
 
 
 
Day -12  Morning                     Afternoon 
 
 
 
 
  Evening          
 
 
Day -13   
 
                        Morning                  Afternoon 
 
 
 
               Evening                                                    
    
Day-14          
  Morning                  Afternoon 
 
 
 
 
Patients signature _________________ 
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Apendix-6 
Key 
Total score difference in, pain, swelling mouth opening (trismus), Dry socket, Clinical 
Collection of pus, Temperature. 
Pain       Swelling 
Variables                  Score    Variables         Score 
None   0    None (absent)   0 
Mild   1    Mild (just visible and palpable)
 1 
Moderate  2    Moderate (obvious)           2 
Severe   3    Severe    3 
Could not be worse     4 
 
Trismus (Difference in mouth opening in mm)   Dry socket  
Variables           Score        Variables          Score 
 
None   0           None                   0 
1-5 mm             1           Yes      1 
6-10 mm  2 
11-15 mm  3 
16-20 mm  4 
 >20 mm  5 
 
Clinical collection of pus    Temperature  (>38° C)  
   
Variables         Score   Variables                  Score 
None   0    No           0 
Yes   1             Yes (>38° C)          1 
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Appendix (Results) 
 
Table-I Treatment Groups Infection day 3 Cross-tabulation 
 
Infection day 3 
  No Yes Total 
Count 47 1 48One dose of 1gm only 
% within T_Group 97.9% 2.1% 100.0%
Count 46 2 48Placebo of group 1 
% within T_Group 95.8% 4.2% 100.0%
Count 46 1 47Two days of antibiotics 
% within T_Group 97.9% 2.1% 100.0%
Count 46 1 47
T_Group 
Placebo of group 2 
% within T_Group 97.9% 2.1% 100.0%
Count 185 5 190Total 
% within T_Group 97.4% 2.6% 100.0%
  
Table I shows the occurrence of infection after 3 days of surgery in the treatment groups 
 
 
 
Table -II Chi-Square Tests 
 
  Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .344(b) 1 .557     
Continuity 
Correction(a) .000 1 1.000     
Likelihood Ratio .351 1 .554     
Fisher's Exact Test       1.000 .500 
Linear-by-Linear 
Association .341 1 .560    
N of Valid Cases 96         
 
a Computed only for a 2x2 table 
b 2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.50. 
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  Table - III Treatment Group I & II Infection day 3 Cross tabulations 
 
Infection day 3 
  No Yes Total 
Count 47 1 48One dose of 1gm only 
% within T_Group 97.9% 2.1% 100.0%
Count 46 1 47
T_Group 
Two days of antibiotics 
% within T_Group 97.9% 2.1% 100.0%
Count 93 2 95Total 
% within T_Group 97.9% 2.1% 100.0%
 
Table III shows infection rates of two treatment groups after third day of surgery. Forty eight patients were 
operated in group I compared to 47 in group II.   
 
 
 
Table - IV Chi-Square Tests 
 
  Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .000(b) 1 .988    
Continuity 
Correction(a) .000 1 1.000    
Likelihood Ratio .000 1 .988    
Fisher's Exact Test    1.000 .747 
Linear-by-Linear 
Association .000 1 .988    
N of Valid Cases 95      
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected count is .99. 
 
 
 
 
 
Table – V Treatment Group I & II Infection day 7 Cross tabulations 
 
Infection day 7 
  No Yes Total 
Count 48 0 48One dose of 1gm only 
% within T_Group 100.0% .0% 100.0%
Count 46 1 47
T_Group 
Two days of antibiotics 
% within T_Group 97.9% 2.1% 100.0%
Total Count 94 1 95
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  % within T_Group 98.9% 1.1% 100.0%
 
Table V shows prevalence of infection in the two treatment groups after seven days of surgery. No infection 
was found in group I compared to one in group II.  
 
Table – VI Chi-Square Tests 
 
  Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.032(b) 1 .310    
Continuity 
Correction(a) .000 1 .992    
Likelihood Ratio 1.418 1 .234    
Fisher's Exact Test    .495 .495 
Linear-by-Linear 
Association 1.021 1 .312    
N of Valid Cases 95      
 
a  Computed only for a 2x2 table 
b  2 cells (50.0%) have expected count less than 5. The minimum expected count is .49. 
 
 
 
 
 
Table -VII Treatment Groups Infection Cross tabulation among the different 
treatment groups 
 
Infection_t
otal 
  1.00 Total 
Count 1 1 One dose of 1gm only 
% within T_Group 100.0% 100.0% 
Count 2 2 Placebo of group 1 
% within T_Group 100.0% 100.0% 
Count 1 1 Two days of antibiotics 
% within T_Group 100.0% 100.0% 
Count 1 1 
T_Group 
Placebo of group 2 
% within T_Group 100.0% 100.0% 
Count 5 5 Total 
% within T_Group 100.0% 100.0% 
 
Table shows occurrence of infection among the two treatment groups and placebo. Total five infections were 
found. Placebo of group I show higher numbers of infection compared to other treatment groups. These 
results are statistically not significant  
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Table -VII Multiple Comparisons Tukey HSD 
 
95% Confidence Interval 
(I) Type P&GRms 
mandible 
(J) Type P&GRms 
mandible 
Mean 
Difference 
(I-J) Std. Error Sig. Lower Bound Upper Bound 
Class II -.22 .137 .244 -.54 .10 Class I 
Class III -1.53(*) .500 .007 -2.71 -.34 
Class II Class I .22 .137 .244 -.10 .54 
  Class III -1.31(*) .492 .023 -2.47 -.14 
Class I 1.53(*) .500 .007 .34 2.71 Class III 
Class II 1.31(*) .492 .023 .14 2.47 
 
 
                Based on observed means. 
• The mean difference is significant at the .05 level 
 
Table - 9 Test Within-Subjects  
Source   
Type III Sum 
of Squares df Mean Square F Sig. 
Sphericity Assumed 12.112 2 6.056 30.416 .000 
Greenhouse-Geisser 12.112 1.594 7.597 30.416 .000 
Huynh-Feldt 12.112 1.635 7.408 30.416 .000 
Time 
Lower-bound 12.112 1.000 12.112 30.416 .000 
Sphericity Assumed 1.613 2 .807 4.052 .019 
Greenhouse-Geisser 1.613 1.594 1.012 4.052 .027 
Huynh-Feldt 1.613 1.635 .987 4.052 .026 
time * T_Group 
Lower-bound 1.613 1.000 1.613 4.052 .047 
Sphericity Assumed 37.032 186 .199     
Greenhouse-Geisser 37.032 148.262 .250     
Huynh-Feldt 37.032 152.057 .244     
Error(time) 
Lower-bound 37.032 93.000 .398     
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Table -10 Tests of Between-Subjects Effects Transformed Variable: Average 
Source 
Type III Sum 
of Squares Df Mean Square F Sig. 
Intercept 19.844 1 19.844 40.810 .000 
T_Group 1.374 1 1.374 2.826 .096 
Error 45.222 93 .486     
 
 
 
Table -XI Infection at third day after surgery 
 
Infection day 3 
 No Yes Total 
Count  1 48 One dose of 1gm only 
% within T-Group 97.9% 2.1% 100.0% 
Count 46 2 48 Placebo of group 1 
% within T-Group 95.8% 4.2% 100.0% 
Count 46 1 47 Two days of antibiotics 
% within T-Group 97.9% 2.1% 100.0% 
Count 46 1 47 
T-Group 
Placebo of group 2 
% within T-Group 97.9% 2.1% 100.0% 
Count 185 5 190 Total 
% within T-Group 97.4% 2.6% 100.0% 
 
Table shows the prevalence of infection in two treatment groups after third day of surgery 
 
 
 
Table –XII Chi-Square Tests 
 
 Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .000(b) 1 1.000   
Continuity 
Correction(a) .000 1 1.000   
Likelihood Ratio .000 1 1.000   
Fisher's Exact Test    1.000 .753 
Linear-by-Linear 
Association .000 1 1.000   
N of Valid Cases 94     
 
         A- Computed only for a 2x2 table 
         B- 2 cells (50.0%) have expected count less than 5. The minimum expected count is 
              1.00                                         
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Figure-1 Percentage of infection on day 3 
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